Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;35(6):619-641.
doi: 10.1007/s40263-021-00823-y. Epub 2021 May 21.

Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention

Affiliations
Review

Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention

Erica Bell et al. CNS Drugs. 2021 Jun.

Abstract

Feeling irritable is a common experience, both in health and disease. In the context of psychiatric illnesses, it is a transdiagnostic phenomenon that features across all ages, and often causes significant distress and impairment. In mood disorders, irritability is near ubiquitous and plays a central role in diagnosis and yet, despite its prevalence, it remains poorly understood. A neurobiological model of irritability posits that, in children and adolescents, it is consequent upon deficits in reward and threat processing, involving regions such as the amygdala and frontal cortices. In comparison, in adults with mood disorders, the few studies that have been conducted implicate the amygdala, orbitofrontal cortices, and hypothalamus; however, the patterns of activity in these areas are at variance with the findings in youth. These age-related differences seem to extend to the neurochemistry of irritability, with links between increased monoamine transmission and irritability evident in adults, but aberrant levels of, and responses to, dopamine in youth. Presently, there are no specific treatments that have significant efficacy in reducing irritability in mood disorders. However, treatments that hold some potential and warrant further exploration include agents that act on serotonergic and dopaminergic systems, especially as irritability may serve as a prognostic indicator for overall clinical responsiveness to specific medications. Therefore, for understanding and treatment of irritability to advance meaningfully, it is imperative that an accurate definition and means of measuring irritability are developed. To achieve this, it is necessary that the subjective experience of irritability, both in health and illness, is better understood. These insights will inform an accurate, comprehensive, and valid interrogation of the qualities of irritability in health and illness, and allow not only a clinical appreciation of the phenomenon, but also a deeper understanding of its important role within the development and manifestation of mood disorders.

PubMed Disclaimer

References

    1. Toohey MJ. Irritability characteristics and parameters in an international sample. J Affect Disord. 2019. https://doi.org/10.1016/j.jad.2019.11.021 . - DOI - PubMed
    1. Toohey MJ, DiGiuseppe R. Defining and measuring irritability: Construct clarification and differentiation. Clin Psychol Rev. 2017;53:93–108. https://doi.org/10.1016/j.cpr.2017.01.009 . - DOI - PubMed
    1. Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC. The importance of irritability as a symptom of major depressive disorder: results from the national comorbidity survey replication. Mol Psychiatry. 2010;15(8):856–67. https://doi.org/10.1038/mp.2009.20 . - DOI - PubMed
    1. Brotman MA, Kircanski K, Leibenluft E. Irritability in children and adolescents. Annu Rev Clin Psychol. 2017;13(1):317–41. https://doi.org/10.1146/annurev-clinpsy-032816-044941 . - DOI - PubMed
    1. Mayes SD, Waxmonsky JD, Calhoun SL, Bixler EO. Disruptive mood dysregulation disorder symptoms and association with oppositional defiant and other disorders in a general population child sample. J Child Adolesc Psychopharmacol. 2016;26(2):101–6. https://doi.org/10.1089/cap.2015.0074 . - DOI - PubMed - PMC

LinkOut - more resources